Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 21889228)

1.

Systems biology of infectious diseases: a focus on fungal infections.

SantamarĂ­a R, Rizzetto L, Bromley M, Zelante T, Lee W, Cavalieri D, Romani L, Miller B, Gut I, Santos M, Pierre P, Bowyer P, Kapushesky M.

Immunobiology. 2011 Nov;216(11):1212-27. doi: 10.1016/j.imbio.2011.08.004. Epub 2011 Aug 16. Review.

PMID:
21889228
2.

Friend or foe: using systems biology to elucidate interactions between fungi and their hosts.

Rizzetto L, Cavalieri D.

Trends Microbiol. 2011 Oct;19(10):509-15. doi: 10.1016/j.tim.2011.07.007. Epub 2011 Aug 24. Review.

PMID:
21871806
3.

Systems biology of host-fungus interactions: turning complexity into simplicity.

Tierney L, Kuchler K, Rizzetto L, Cavalieri D.

Curr Opin Microbiol. 2012 Aug;15(4):440-6. doi: 10.1016/j.mib.2012.05.001. Epub 2012 Jun 19. Review.

4.

Host-fungal interactions: key players of antifungal immunity.

Salek-Ardakani S, Cota E, Bignell E.

Expert Rev Anti Infect Ther. 2012 Feb;10(2):149-51. doi: 10.1586/eri.11.169.

PMID:
22339189
5.

Complexity and dynamics of host-fungal interactions.

Cottier F, Pavelka N.

Immunol Res. 2012 Sep;53(1-3):127-35. doi: 10.1007/s12026-012-8265-y. Review.

PMID:
22415250
6.

Fungal pathogens research: novel and improved molecular approaches for the discovery of antifungal drug targets.

Tournu H, Serneels J, Van Dijck P.

Curr Drug Targets. 2005 Dec;6(8):909-22. Review.

PMID:
16375674
7.

Antibody-mediated protective immunity in fungal infections.

Magliani W, Conti S, Arseni S, Salati A, Ravanetti L, Maffei DL, Giovati L, Polonelli L.

New Microbiol. 2005 Oct;28(4):299-309. Review.

PMID:
16386014
8.

On the way toward systems biology of Aspergillus fumigatus infection.

Albrecht D, Kniemeyer O, Mech F, Gunzer M, Brakhage A, Guthke R.

Int J Med Microbiol. 2011 Jun;301(5):453-9. doi: 10.1016/j.ijmm.2011.04.014. Epub 2011 May 8. Review.

PMID:
21555243
9.

The role of Dectin-1 in the host defence against fungal infections.

Drummond RA, Brown GD.

Curr Opin Microbiol. 2011 Aug;14(4):392-9. doi: 10.1016/j.mib.2011.07.001. Epub 2011 Jul 29. Review.

PMID:
21803640
10.

Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans.

Jouault T, Sarazin A, Martinez-Esparza M, Fradin C, Sendid B, Poulain D.

Cell Microbiol. 2009 Jul;11(7):1007-15. doi: 10.1111/j.1462-5822.2009.01318.x. Epub 2009 Mar 18. Review.

PMID:
19388906
11.

Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi.

Zelante T, Montagnoli C, Bozza S, Gaziano R, Bellocchio S, Bonifazi P, Moretti S, Fallarino F, Puccetti P, Romani L.

Adv Exp Med Biol. 2007;590:209-21. Review. No abstract available.

PMID:
17191388
12.

Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.

Willins DA, Kessler M, Walker SS, Reyes GR, Cottarel G.

Curr Pharm Des. 2002;8(13):1137-54. Review.

PMID:
12052224
13.

Immune escape of the human facultative pathogenic yeast Candida albicans: the many faces of the Candida Pra1 protein.

Zipfel PF, Skerka C, Kupka D, Luo S.

Int J Med Microbiol. 2011 Jun;301(5):423-30. doi: 10.1016/j.ijmm.2011.04.010. Epub 2011 May 11. Review.

PMID:
21565550
14.

Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.

Stergiopoulou T, Meletiadis J, Sein T, Papaioannidou P, Tsiouris I, Roilides E, Walsh TJ.

J Antimicrob Chemother. 2009 Feb;63(2):343-8. doi: 10.1093/jac/dkn473. Epub 2008 Dec 24.

15.

Antifungal type 1 responses are upregulated in IL-10-deficient mice.

Del Sero G, Mencacci A, Cenci E, d'Ostiani CF, Montagnoli C, Bacci A, Mosci P, Kopf M, Romani L.

Microbes Infect. 1999 Dec;1(14):1169-80.

PMID:
10580272
16.

Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity).

Perfect JR, Pfaller MA, Ostrosky-Zeichner L, Kontoyiannis DP.

Am J Med. 2011 Oct;124(10):S2-3. doi: 10.1016/j.amjmed.2011.08.001. No abstract available.

PMID:
21962326
17.

Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.

Pitarch A, Nombela C, Gil C.

Methods Mol Biol. 2009;470:369-411. doi: 10.1007/978-1-59745-204-5_26.

PMID:
19089396
18.

Novel strategies in antifungal lead discovery.

Jiang B, Bussey H, Roemer T.

Curr Opin Microbiol. 2002 Oct;5(5):466-71. Review.

PMID:
12354552
19.

Novel immunotherapeutic strategies for invasive fungal disease.

van Spriel AB.

Curr Drug Targets Cardiovasc Haematol Disord. 2003 Sep;3(3):209-17. Review.

PMID:
12871039
20.

Computational biology approaches for selecting host-pathogen drug targets.

Brown JR, Magid-Slav M, Sanseau P, Rajpal DK.

Drug Discov Today. 2011 Mar;16(5-6):229-36. doi: 10.1016/j.drudis.2011.01.008. Epub 2011 Jan 28. Review.

PMID:
21277381
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk